• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酚红是犬舌动脉和人血小板中的血栓素A2/前列腺素H2受体拮抗剂。

Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.

作者信息

Greenberg S S, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K

机构信息

Louisiana State University, Department of Medicine, New Orleans.

出版信息

J Pharmacol Exp Ther. 1994 Mar;268(3):1352-61.

PMID:8138950
Abstract

Phenol red (PR) is used as a pH indicator in cell culture medium. We found that cell culture medium containing PR relaxed canine lingual arteries (LA) contracted by the thromboxane A2/prostaglandin endoperoxide (TPE) receptor agonist (15S)-hydroxy-11-alpha-9-alpha- (epoxymethano)prosta-5Z,13E-dienoic acid (U46619). We tested the effect of PR and the TPE receptor antagonist ONO-3708 on U46619, prostaglandin F2 alpha (PGF2 alpha), phenylephrine (PE) and potassium chloride (KCl)-induced contraction of the LA and on human platelet aggregation to U46619, ADP, arachidonic acid (AA), A23187 and thrombin. U46619, PGF2 alpha, KCl and PE produced equal tension development of the LA. PR relaxed the LA contracted with U46619 and PGF2 alpha with IC50 concentrations of 18.3 +/- 10 and 37.3 +/- 8.8 microM, respectively. ONO-3708 inhibited the contractions to U46619 and PGF2 alpha with IC50 of 9.4 +/- 2.2 and 12.2 +/- 2.2 nM, respectively. However, PR (300 microM) and ONO-3708 (300 nM) did not affect contraction of the LA to KCl or PE. PR inhibited human platelet aggregation, in vitro, to AA and U46619 and second wave aggregation to ADP but did not affect thrombin or first wave ADP-mediated platelet aggregation. PR inhibited U46619 and AA-induced changes in cyclic AMP and Fura-2 calcium transients in platelets and LA. However, PR did not affect the activation of cyclic AMP or intracellular calcium ion in platelets or calcium influx and the release of intracellular calcium ion in canine LA produced by ryanodine, KCl and PE. The concentration of PR in many culture media is between 40 and 70 microM. The data support the conclusion that PR, in concentrations used as a pH indicator, is a selective antagonist of TPE receptors.

摘要

酚红(PR)在细胞培养基中用作pH指示剂。我们发现,含有PR的细胞培养基可舒张由血栓素A2/前列腺素内过氧化物(TPE)受体激动剂(15S)-羟基-11-α-9-α-(环氧亚甲基)前列腺-5Z,13E-二烯酸(U46619)引起收缩的犬舌动脉(LA)。我们测试了PR和TPE受体拮抗剂ONO-3708对U46619、前列腺素F2α(PGF2α)、去氧肾上腺素(PE)和氯化钾(KCl)诱导的LA收缩的影响,以及对人血小板对U46619、ADP、花生四烯酸(AA)、A23187和凝血酶聚集的影响。U46619、PGF2α、KCl和PE使LA产生同等程度的张力变化。PR可舒张由U46619和PGF2α引起收缩的LA,其IC50浓度分别为18.3±10和37.3±8.8μM。ONO-3708抑制对U46619和PGF2α的收缩,其IC50分别为9.4±2.2和12.2±2.2 nM。然而,PR(300μM)和ONO-3708(300 nM)不影响LA对KCl或PE的收缩。PR在体外抑制人血小板对AA和U46619的聚集以及对ADP的第二波聚集,但不影响凝血酶或第一波ADP介导的血小板聚集。PR抑制血小板和LA中U46619和AA诱导的环磷酸腺苷(cAMP)和Fura-2钙瞬变的变化。然而,PR不影响血小板中环磷酸腺苷的激活或细胞内钙离子,也不影响犬LA中由ryanodine、KCl和PE引起的钙离子内流和细胞内钙离子释放。许多培养基中PR的浓度在40至70μM之间。这些数据支持以下结论:用作pH指示剂的浓度下,PR是TPE受体的选择性拮抗剂。

相似文献

1
Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.酚红是犬舌动脉和人血小板中的血栓素A2/前列腺素H2受体拮抗剂。
J Pharmacol Exp Ther. 1994 Mar;268(3):1352-61.
2
Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.8-表-前列腺素F2α及其他F系列前列腺素在人血小板中的抗聚集活性及其与血栓素A2/前列腺素H2受体的结合
J Pharmacol Exp Ther. 1994 Sep;270(3):1192-6.
3
Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.血栓素A2介导的形状改变:在兔血小板中独立于Gq-磷脂酶C-Ca2+途径
Br J Pharmacol. 1996 Mar;117(6):1095-104. doi: 10.1111/j.1476-5381.1996.tb16702.x.
4
Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.肉桂亲和素的药理学特性研究,一种新型血栓素合酶和血栓素A2受体双重抑制剂。
Br J Pharmacol. 1994 Mar;111(3):906-12. doi: 10.1111/j.1476-5381.1994.tb14824.x.
5
Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.人和犬血小板及血管中血栓素A2/前列腺素H2受体的药理学特性:不同受体的证据
J Pharmacol Exp Ther. 1985 May;233(2):418-24.
6
Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.模拟物U46619对血小板血栓素A2/前列腺素H2受体的脱敏作用
J Pharmacol Exp Ther. 1988 Dec;247(3):1133-8.
7
Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.新型血管紧张素II AT(1)受体拮抗剂厄贝沙坦可预防血栓素A(2)诱导的犬冠状动脉血管收缩和人血小板聚集。
J Pharmacol Exp Ther. 2000 Jan;292(1):238-46.
8
Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.使用一系列新型前列腺素F2α的9,11-环碳酸酯衍生物证明人血栓素受体的异质性。
Br J Pharmacol. 1996 Mar;117(6):1171-80. doi: 10.1111/j.1476-5381.1996.tb16712.x.
9
7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.7-[(1R,2S,3S,5R)-6,6-二甲基-3-(4-碘苯磺酰氨基)双环[3.1.1]庚-2-基]-5(Z)-庚烯酸:一种新型的血小板血栓素A2/前列腺素H2受体高亲和力放射性标记拮抗剂。
J Pharmacol Exp Ther. 1992 Aug;262(2):632-7.
10
Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.新型血栓素A2拮抗剂瓦匹前列素对犬离体血管的作用。
Arzneimittelforschung. 1992 Nov;42(11):1318-22.

引用本文的文献

1
Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red.pH指示剂染料酚红对P2X受体亚型ATP反应的拮抗作用。
Br J Pharmacol. 2005 Jun;145(3):313-22. doi: 10.1038/sj.bjp.0706187.
2
Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.抗肿瘤药物伊立替康释放的血栓素A2是离体大鼠结肠中氯离子分泌的一种新型刺激物。
J Physiol. 1997 Nov 15;505 ( Pt 1)(Pt 1):133-44. doi: 10.1111/j.1469-7793.1997.133bc.x.